VRTX

Vertex Pharmaceuticals Incorporated

419.82 USD
+0.21 (+0.05%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Vertex Pharmaceuticals Incorporated stock is down -4.52% since 30 days ago. The next earnings date is Apr 29, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 42.42% of the previous 32 February’s closed higher than January. In the last 10 Unusual Options Trades, there were 4 CALLs, 6 PUTs. 69% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
16 Feb 14:34 17 Jan, 2025 220.00 CALL 3 12
16 Feb 19:39 17 Jan, 2025 290.00 CALL 2 53
16 Feb 20:23 15 Mar, 2024 470.00 CALL 456 627
16 Feb 20:52 17 Jan, 2025 500.00 PUT 8 13
16 Feb 20:53 19 Apr, 2024 420.00 PUT 20 360
20 Feb 16:58 21 Jun, 2024 410.00 PUT 25 195
20 Feb 17:23 21 Jun, 2024 400.00 PUT 25 120
20 Feb 17:38 20 Jun, 2025 400.00 PUT 40 1
21 Feb 14:35 16 Jan, 2026 520.00 CALL 6 681
21 Feb 15:32 21 Jun, 2024 440.00 PUT 11 34

About Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with CF 6 years of age or older who have at least one F508del mutation. Its pipeline includes VX-864 for the treatment of AAT deficiency, which is in Phase 2 clinical trial.

  • Cantor Fitzgerald
    Tue Feb 20, 12:44
    buy
    confirm
  • Wolfe Research
    Thu Feb 15, 06:25
    buy
    initial
  • Cantor Fitzgerald
    Tue Feb 6, 14:36
    buy
    confirm
  • JP Morgan
    Tue Feb 6, 14:22
    buy
    confirm
  • Wells Fargo
    Tue Feb 6, 11:13
    buy
    confirm
  • RBC Capital
    Tue Feb 6, 11:01
    hold
    confirm
  • Barclays
    Tue Feb 6, 10:50
    buy
    confirm
  • Evercore Partners
    Tue Feb 6, 08:32
    hold
    downgrade
  • HC Wainwright & Co.
    Tue Feb 6, 06:44
    buy
    confirm
  • Bernstein
    Fri Feb 2, 06:23
    hold
    downgrade
  • JP Morgan
    Thu Feb 1, 09:37
    buy
    confirm
  • Truist Securities
    Wed Jan 31, 14:51
    buy
    confirm
  • Goldman Sachs
    Wed Jan 31, 11:08
    buy
    confirm
  • Maxim Group
    Wed Jan 31, 10:04
    hold
    downgrade
  • Cantor Fitzgerald
    Wed Jan 24, 11:40
    buy
    confirm
  • Canaccord Genuity
    Wed Jan 24, 06:21
    sell
    downgrade